Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / halozyme s strategic partnerships fueling next gen t

NVS - Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics

Novartis AG

2024-04-10 06:50:33 ET

Summary

  • Halozyme's ENHANZE technology drives growth, with Q4 2023 revenue up 27% YoY, projecting $915-$985 million in 2024.
  • Key revenue from royalties, notably Darzalex Faspro, with a healthy financial state highlighted by a strong current ratio and stock repurchasing.
  • Future growth fueled by subcutaneous versions of blockbuster drugs like Opdivo, Ocrevus, and Vyvgart, despite some setbacks.
  • Investment recommendation: Strong Buy, based on significant expansion potential, balanced by a note on high leverage and operational risks.

Introduction

For further details see:

Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics
Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...